The launch of opicapone for Parkinson’s disease: negatives versus positives

Ana Castro Caldas, Tiago Teodoro, Joaquim J Ferreira
  • Expert Opinion on Drug Safety, February 2018, Taylor & Francis
  • DOI: 10.1080/14740338.2018.1433659

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/14740338.2018.1433659

The following have contributed to this page: Joaquim Ferreira

In partnership with: